Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

MARINE MEDICAL ANTIBES : revenue, balance sheet and financial ratios

MARINE MEDICAL ANTIBES is a French company founded 18 years ago, specialized in the sector Formation continue d'adultes. Based in ANTIBES (06600), this company of category PME shows in 2013 a revenue of 302 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MARINE MEDICAL ANTIBES (SIREN 501001994)
Indicator 2013
Revenue 302 083 €
Net income 32 492 €
EBITDA 45 195 €
Net margin 10.8%

Revenue and income statement

En 2013, MARINE MEDICAL ANTIBES alcanza unos ingresos de 302 k€. Tras deducir el consumo (125 k€), el margen bruto se sitúa en 177 k€, es decir, una tasa del 58%. El EBITDA alcanza 45 k€, representando el 15.0% de los ingresos. Este nivel de margen operativo es satisfactorio para el sector. El resultado neto asciende a 32 k€, es decir, el 10.8% de los ingresos.

Revenue (2013) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

302 083 €

Gross margin (2013) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

176 669 €

EBITDA (2013) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

45 195 €

EBIT (2013) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

41 600 €

Net income (2013) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

32 492 €

EBITDA margin (2013) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

15.0%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

El ratio de endeudamiento (= Deuda financiera / Fondos propios x 100) se sitúa en 74%. El nivel de deuda es alto: el margen de negociación con los bancos se reduce. La autonomía financiera (= Fondos propios / Total activo x 100) alcanza el 47%. Esta alta autonomía significa que la empresa financia la mayoría de sus activos con fondos propios. La capacidad de reembolso indica que se necesitarían 0.8 años de flujo de caja. Este corto período demuestra una excelente sostenibilidad de la deuda. El flujo de caja representa el 11.9% de los ingresos. Este alto nivel proporciona una fuerte capacidad de autofinanciación.

Debt ratio (2013) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

74.226%

Financial autonomy (2013) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

46.794%

Cash flow / Revenue (2013) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

11.939%

Repayment capacity (2013) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.784

Asset age ratio (2013) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

36.6%

Solvency indicators evolution
MARINE MEDICAL ANTIBES

Sector positioning

Ratio de endeudamiento
74.23 2013
2013
Q1: 0.0
Med: 0.0
Q3: 11.08
Vigilar

En 2013, el ratio de endeudamiento de MARINE MEDICAL ANTIBES (74.23) se sitúa en el top 25% del sector. Este ratio mide el peso de la deuda en relación con el patrimonio. Un ratio alto puede indicar dependencia excesiva de financiación externa.

Autonomía financiera
46.79% 2013
2013
Q1: 0.0%
Med: 12.79%
Q3: 45.59%
Excelente

En 2013, el autonomía financiera de MARINE MEDICAL ANTIBES (46.8%) se sitúa en el top 25% del sector. Este ratio representa la parte del patrimonio en la financiación total. Alta autonomía refleja independencia financiera y capacidad para absorber choques.

Capacidad de reembolso
0.78 ans 2013
2013
Q1: 0.0 ans
Med: 0.0 ans
Q3: 0.13 ans
Vigilar

En 2013, el capacidad de reembolso de MARINE MEDICAL ANTIBES (0.8 an) se sitúa en el top 25% del sector. Este ratio indica el número de años necesarios para pagar la deuda con flujo de caja. Una duración larga puede señalar deuda pesada relativa a la capacidad de pago.

Liquidity ratios

El ratio de liquidez se sitúa en 60.06. La empresa tiene 2€ de activos líquidos por cada 1€ de deuda a corto plazo. El ratio de cobertura de intereses (= EBIT / Gastos financieros) es de 5.2x. El resultado de explotación cubre muy ampliamente los gastos financieros.

Liquidity ratio (2013) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

60.061

Interest coverage (2013) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

5.233

Liquidity indicators evolution
MARINE MEDICAL ANTIBES

Sector positioning

Ratio de liquidez
60.06 2013
2013
Q1: 98.5
Med: 145.49
Q3: 238.72
Vigilar

En 2013, el ratio de liquidez de MARINE MEDICAL ANTIBES (60.06) se sitúa en el 25% más bajo del sector. Este ratio mide la capacidad de cubrir deuda a corto plazo con activos corrientes. Un ratio inferior a 1 puede señalar tensiones potenciales de flujo de caja.

Cobertura de intereses
5.23x 2013
2013
Q1: 0.0x
Med: 0.0x
Q3: 0.53x
Excelente

En 2013, el cobertura de intereses de MARINE MEDICAL ANTIBES (5.2x) se sitúa en el top 25% del sector. Este ratio indica cuántas veces el resultado operativo cubre los gastos de intereses. Alta cobertura significa que los gastos financieros pesan poco en la rentabilidad.

Working capital requirement (WCR) and payment terms

El fondo de maniobra operativo (FM) mide el desfase temporal de tesorería. Plazo medio de cobro a clientes: 0 días. Plazo proveedores: 12 días. Situación favorable. El FM es negativo (-5 días): las operaciones generan estructuralmente tesorería.

Operating WCR (2013) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

-4 531 €

Customer credit (2013) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2013) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

12 j

Inventory turnover (2013) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2013) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

-5 j

WCR and payment terms evolution
MARINE MEDICAL ANTIBES

Positioning of MARINE MEDICAL ANTIBES in its sector

Comparison with sector Formation continue d'adultes

Valuation estimate

Based on 134 transactions of similar company sales (all years), the value of MARINE MEDICAL ANTIBES is estimated at 100 473 € (range 35 682€ - 293 978€). With an EBITDA of 45 195€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2013
134 transactions
35k€ 100k€ 293k€
100 473 € Range: 35 682€ - 293 978€
NAF 5 all-time

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
45 195 € × 2.2x
Estimation 97 990 €
35 509€ - 254 859€
Revenue Multiple 30%
302 083 € × 0.36x
Estimation 107 976 €
36 025€ - 211 114€
Net Income Multiple 20%
32 492 € × 2.9x
Estimation 95 428 €
35 602€ - 516 074€
How is this estimate calculated?

This estimate is based on the analysis of 134 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Formation continue d'adultes)

Compare MARINE MEDICAL ANTIBES with other companies in the same sector:

Voir toutes les statistiques du secteur Formation continue d'adultes

Frequently asked questions about MARINE MEDICAL ANTIBES

What is the revenue of MARINE MEDICAL ANTIBES ?

The revenue of MARINE MEDICAL ANTIBES in 2013 is 302 k€.

Is MARINE MEDICAL ANTIBES profitable?

Yes, MARINE MEDICAL ANTIBES generated a net profit of 32 k€ in 2013.

Where is the headquarters of MARINE MEDICAL ANTIBES ?

The headquarters of MARINE MEDICAL ANTIBES is located in ANTIBES (06600), in the department Alpes-Maritimes.

Where to find the tax return of MARINE MEDICAL ANTIBES ?

The tax return of MARINE MEDICAL ANTIBES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MARINE MEDICAL ANTIBES operate?

MARINE MEDICAL ANTIBES operates in the sector Formation continue d'adultes (NAF code 85.59A). See the 'Sector positioning' section above to compare the company with its competitors.